rs62640939
Variant summary
Our verdict is Benign. Variant got -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBS1BS2
The NM_002529.4(NTRK1):c.2272G>A(p.Ala758Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000954 in 1,601,278 control chromosomes in the GnomAD database, including 12 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. A758A) has been classified as Likely benign.
Frequency
Consequence
NM_002529.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NTRK1 | NM_002529.4 | c.2272G>A | p.Ala758Thr | missense_variant | 17/17 | ENST00000524377.7 | |
NTRK1 | NM_001012331.2 | c.2254G>A | p.Ala752Thr | missense_variant | 16/16 | ||
NTRK1 | NM_001007792.1 | c.2164G>A | p.Ala722Thr | missense_variant | 17/17 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NTRK1 | ENST00000524377.7 | c.2272G>A | p.Ala758Thr | missense_variant | 17/17 | 1 | NM_002529.4 | P4 |
Frequencies
GnomAD3 genomes ? AF: 0.00526 AC: 800AN: 152178Hom.: 6 Cov.: 32
GnomAD3 exomes AF: 0.00119 AC: 268AN: 224318Hom.: 1 AF XY: 0.000871 AC XY: 106AN XY: 121638
GnomAD4 exome AF: 0.000502 AC: 727AN: 1448982Hom.: 6 Cov.: 31 AF XY: 0.000422 AC XY: 304AN XY: 719716
GnomAD4 genome ? AF: 0.00526 AC: 801AN: 152296Hom.: 6 Cov.: 32 AF XY: 0.00540 AC XY: 402AN XY: 74468
ClinVar
Submissions by phenotype
Hereditary insensitivity to pain with anhidrosis Benign:6
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Dec 16, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 28, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. - |
Benign, criteria provided, single submitter | clinical testing | Invitae | Jan 31, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Apr 11, 2023 | - - |
Likely benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Nov 22, 2023 | - - |
Likely benign, criteria provided, single submitter | clinical testing | KCCC/NGS Laboratory, Kuwait Cancer Control Center | Jul 07, 2023 | - - |
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 25, 2019 | This variant is associated with the following publications: (PMID: 26215504) - |
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Oct 02, 2017 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at